Literature DB >> 3767253

Radioimmunoassay of buprenorphine with iodine label: analysis of buprenorphine and metabolites in human plasma.

C W Hand, D Baldwin, R A Moore, M C Allen, H J McQuay.   

Abstract

Quantitative analysis of potent opiate drugs in plasma by radioimmunoassay is potentially inaccurate because of the occurrence of cross-reacting metabolites. This paper describes the chemical synthesis of buprenorphine-3-O-glucuronide, a metabolite of buprenorphine, and an extraction procedure coupled with radioimmunoassay which allows the sensitive and specific measurement of buprenorphine using an iodinated buprenorphine derivative. The measurement of extracted and unextracted samples using two different antisera allowed investigation of the metabolism of buprenorphine. In four patients who had taken sublingual buprenorphine for at least one month, N-dealkyl buprenorphine was present in similar concentrations to those of buprenorphine, while buprenorphine-3-O-glucuronide was present in two to three times those concentrations.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3767253     DOI: 10.1177/000456328602300105

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  4 in total

1.  The pharmacokinetics and physiological effects of buprenorphine infusion in premature neonates.

Authors:  D A Barrett; J Simpson; N Rutter; T Kurihara-Bergstrom; P N Shaw; S S Davis
Journal:  Br J Clin Pharmacol       Date:  1993-09       Impact factor: 4.335

2.  High-sensitivity analysis of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in plasma and urine by liquid chromatography-mass spectrometry.

Authors:  Karen J Regina; Evan D Kharasch
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-09-08       Impact factor: 3.205

3.  Comparison of anesthetic effects of epidural and intravenous administration of buprenorphine during operation.

Authors:  E Yonemura; K Fukushima
Journal:  J Anesth       Date:  1990-07       Impact factor: 2.078

Review 4.  Clinical pharmacology and dosing regimen optimization of neonatal opioid withdrawal syndrome treatments.

Authors:  Fei Tang; Chee M Ng; Henrietta S Bada; Markos Leggas
Journal:  Clin Transl Sci       Date:  2021-05-01       Impact factor: 4.689

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.